Eliem Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Eliem Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Eliem Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eliem Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $1.6M | 234k | 6.85 |
| 2025-12-31 | $594k | 149k | 4.00 |
| 2025-09-30 | $174k | 86k | 2.01 |
| 2025-06-30 | $123k | 100k | 1.24 |
| 2024-12-31 | $409k | 227k | 1.80 |
| 2024-09-30 | $398k | 78k | 5.09 |
| 2024-06-30 | $70k | 9.9k | 7.11 |
| 2024-03-31 | $4.7k | 1.7k | 2.74 |
| 2023-12-31 | $4.6k | 1.7k | 2.70 |
| 2023-09-30 | $4.5k | 1.7k | 2.63 |
| 2023-06-30 | $4.8k | 1.7k | 2.80 |
| 2022-12-31 | $531 | 145 | 3.67 |
| 2022-06-30 | $28k | 6.6k | 4.26 |
| 2022-03-31 | $0 | 5.7k | 0.00 |